Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 408
Last updated 2024-01-18
Summary
The purpose of this study is to assess the feasibility of investigational Positron Emission Tomography (PET) imaging using the new generation digital detector PET technology for new procedures beyond the current standard of care.
Conditions
- New-generation Digital PET/CT Imaging
Interventions
- DIAGNOSTIC_TEST
-
Digital PET/CT imaging
Next generation PET/CT imaging
Sponsors & Collaborators
-
Ohio Third Frontier
collaborator OTHER -
University of Cincinnati
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-19
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
PET/MR in Assessing Response to Neoadjuvant Radiation Therapy in the Tx of High Grade Sarcomas
NCT03076333 ·Status: COMPLETED ·Phase: NA
-
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT
NCT03846167 ·Status: ACTIVE_NOT_RECRUITING
-
Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors
NCT00816335 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Positron Emission Tomography in Patients With Breast Cancer
NCT00001385 ·Status: COMPLETED
-
MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study
NCT02334371 ·Status: COMPLETED ·Phase: NA
-
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
NCT02526511 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging
NCT00612326 ·Status: COMPLETED
-
Breast PET Feasibility
NCT03198442 ·Status: COMPLETED ·Phase: NA
-
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
NCT06055764 ·Status: NOT_YET_RECRUITING
-
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
NCT01269593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
NCT00565721 ·Status: COMPLETED ·Phase: PHASE2
-
[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers
NCT01717391 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
NCT05524454 ·Status: COMPLETED ·Phase: NA
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
18F-FSPG PET/CT Imaging in Patients With Cancers
NCT03144622 ·Status: UNKNOWN
-
Translational Development of Photon-counting CT Imaging
NCT03878134 ·Status: COMPLETED ·Phase: NA
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors
NCT01176500 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
18F-FSPG PET/CT for Cancer Patients on Therapy
NCT02599194 ·Status: COMPLETED ·Phase: PHASE2
-
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
NCT04999917 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PET/MRI in Children With Cancer
NCT01839747 ·Status: COMPLETED ·Phase: NA
-
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
NCT01892540 ·Status: COMPLETED ·Phase: NA